Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Education, Medical, Undergraduate; Medical History Taking; Diagnosis
Intervention: Behavioral: Contextualization workshop
Sponsors: University of Illinois; National Board of Medical Examiners
Active, not recruiting - verified March 2010
Condition: Ependymoma
Intervention: Drug: Carboplatin
Sponsors: Children's Memorial Hospital; Brown University
Not yet recruiting - verified March 2010
Condition: Premature Infants
Intervention: Other: Individually customized physiotherapy
Sponsors: University Hospital of North Norway; University of Tromso; St. Olavs Hospital; University of Illinois
Not yet recruiting - verified March 2010
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA) withdrawal and reinstitution
Sponsors: University of Tennessee; Mount Sinai School of Medicine; Children's Memorial Hospital; University of California, San Francisco; The Hospital for Sick Children; University of Colorado, Denver; Children's Hospital Medical Center, Cincinnati; University of Pittsburgh
Not yet recruiting - verified March 2010
Condition: Epilepsy
Intervention:
Sponsors: The Epilepsy Study Consortium; Eisai Inc.; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; H. Lundbeck A/S; Pfizer; Supernus Pharmaceuticals, Inc.; UCB, Inc.
Enrolling by invitation - verified March 2010
Condition: Oral Mucositis
Interventions: Drug: amlexanox; Drug: Vehicle rinse
Sponsors: Access Pharmaceuticals, Inc.; Advanced Clinical Research Services, LLC
Completed - verified March 2010
Condition: PROSTATE CANCER.
Interventions: Drug: Docetaxel and Prednisone; Drug: Docetaxel and Prednisone; Drug: Radiation Therapy
Sponsors: Northwestern University; Genzyme
Not yet recruiting - verified March 2010
Condition: Heart Arrest
Intervention: Other: Preemptive Rapid Response Team intervention
Sponsors: University of Chicago; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Condition: Postoperative Pain
Intervention: Drug: cyclobenzaprine
Sponsor: NorthShore University HealthSystem Research Institute
Not yet recruiting - verified March 2010
Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA); National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Condition: Pulmonary Disease
Intervention: Other: Exercise
Sponsor: University of Chicago
Active, not recruiting - verified March 2010
Condition: Individuals at Risk for Depression
Interventions: Behavioral: AIM Web based intervention + surveillance; Behavioral: AIM web based intervention; Behavioral: Educational website
Sponsor: Northwestern University
Recruiting - verified March 2010
Condition: Epilepsy
Intervention: Drug: Diazepam
Sponsors: University of Chicago; King Pharmaceuticals Research and Development
Recruiting - verified March 2010
Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab; Drug: ranibizumab
Sponsors: Johns Hopkins University; Juvenile Diabetes Research Foundation
Recruiting - verified February 2010
Conditions: Discogenic Pain; Low Back Pain
Interventions: Procedure: Functional anesthetic discography; Procedure: Provocative Discography
Sponsors: Northwestern University; Medtronic Spine LLC
Recruiting - verified February 2010
Condition: Endotracheal Intubation
Interventions: Device: Airtraq; Other: Mac Blade Teaching First
Sponsor: Northwestern University
Recruiting - verified March 2010
Condition: Non-Hodgkin Lymphomas
Intervention: Drug: Ofatumumab
Sponsor: Oncology Specialists, S.C.
Recruiting - verified February 2010
Condition: Insomnia
Intervention: Behavioral: cognitive behavioral therapy for insomnia (CBT-I)
Sponsor: University of Illinois
Recruiting - verified February 2010
Conditions: Pain; Surgery
Interventions: Drug: Placebo; Drug: (study group) will receive a bilateral TAP block using 15 cc of 0.5% ropivacaine on each side
Sponsor: Northwestern University
Recruiting - verified February 2010
Conditions: Pain; Obesity; Surgery
Interventions: Drug: Placebo; Drug: (study group) will receive a bilateral TAP block using 30 cc of 0.5% ropivacaine on each side.
Sponsor: Northwestern University
Recruiting - verified February 2010
Condition: Postoperative Pain
Interventions: Drug: placebo; Drug: Study Drug (0.5% ropivacaine ) injection; Procedure: TAP block
Sponsor: Northwestern University
Not yet recruiting - verified February 2010
Condition: Atopic Dermatitis
Interventions: Other: Standard of care eczema treatment; Device: Accu-patch pellets
Sponsor: Northwestern University
Recruiting - verified February 2010
Conditions: Stage IV Colorectal Cancer; Dignity Therapy
Intervention: Behavioral: Dignity Therapy
Sponsor: Northwestern University
Not yet recruiting - verified February 2010
Conditions: Pain; Breastfeeding
Intervention:
Sponsor: Northwestern University
Recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Behavioral: Multimedia Education; Behavioral: Print Media; Behavioral: Usual and customary waiting room process
Sponsors: Saint Francis Care; American Cancer Society; Feinberg School of Medicine, Northwestern University
Recruiting - verified February 2010
Condition: Diabetes Mellitus
Interventions: Device: Finesse; Device: Pen/Syringe (Usual injection device)
Sponsors: Calibra Medical, Inc.; Nancy Bohannon, MD, Med. Corp.; Henry Ford Health System; Northwestern University; University of Texas Southwestern Medical Center; Joslin Diabetes Center; International Diabetes Center at Park Nicollet
Recruiting - verified March 2010
Conditions: Sedentary Lifestyle; Risk of Disability; Aging
Intervention: Behavioral: Lifestyle modification
Sponsors: University of Florida; National Institute on Aging (NIA); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2010
Condition: Breast Cancer
Intervention: Procedure: Low-Level Laser Therapy
Sponsor: Northwestern University
Not yet recruiting - verified March 2010
Condition: Healthy
Interventions: Other: wheat bran extract; Other: control wheat bran extract
Sponsors: Kellogg Company; Provident Clinical Research; Tufts University; University of Toronto; University of Reading; University of Saskatchewan
Completed - verified February 2010
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
Sponsors: University of Michigan; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (info added by University of Michigan Data Coordinating Center)
Recruiting - verified November 2009
Condition: Parkinson's Disease
Interventions: Drug: Amantadine; Drug: Placebo
Sponsors: Rush University Medical Center; Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified February 2010
All Categories ... University Studies » ... United States » ... Illinois 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
